CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 57 enrolled
Drug / intervention
Apigenindietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06560216
NCT06560216N/ACompleted

Effects of Supplementation of Cryopreservation Medium With Apigenin on Post-thaw Human Sperm

Chulalongkorn University·interventional·Posted Aug 19, 2024·Updated Mar 18, 2025

In Brief

A clinical study evaluating Apigenin for Healthy. Completed, enrolled 57 participants across 2 sites.

Detailed Summary

The goal of this clinical trial is to compare the effect of apigenin supplementation in freezing medium with no apigenin supplementation in freezing medium on post-thaw human sperm motility. It will also evaluate the sperm viability, total antioxidant capacity, and oxidative stress markers. The main questions it aims to answer are: * Does apigenin supplementation in freezing medium improve the post-thaw sperm motility? * Does apigenin supplementation in freezing medium improve the post-thaw sperm viability, total antioxidant capacity, and oxidative stress?

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesThailand
Collaborators--

Timeline

N/ACompletedFinished
20252026
First PostedAug 19, 2024
Enrollment StartOct 28, 2024
Primary CompletionFeb 12, 2025
Study CompletionMar 3, 2025
TodayJul 1, 2026
Enrollment to primary: 3 monthsPosted 1.9 years ago

Interventions

Apigenindietary

0.2 mM in freezing medium